Search This Blog

Thursday, June 13, 2024

'Massachusetts House unanimously approves parentage equality bill'

 Rep. Sarah Peake thought that when Massachusetts became the first state in the nation to legalize same-sex marriage 20 years ago, the reforms would also assign equal parentage rights.

“That wasn’t the case,” the Provincetown Democrat, who is herself married to a woman, said.

Peake and her colleagues hope a bill the House unanimously approved on June 12 will fix “archaic” sections of state law that can make it difficult for LGBTQ families and those who use alternative methods of reproduction, like in vitro fertilization, to establish legal parenthood.

The bill (H. 4672), long a priority for civil rights and LGBTQ activists, would create new pathways and clearer standards for Bay Staters to establish parentage over a child through birth as well as other means such as adoption, surrogacy and marriage.

Supporters warned that gaps in existing law could force, for example, one parent in a same-sex couple to formally adopt their child to gain the same status as a birth parent.

“For many children in the commonwealth, the person they call mom or dad is shunned legally,” said Rep. Michael Day, who co-chairs the Judiciary Committee. “The person that child calls mom or dad has no standing and scant legal rights or recourse. They are shut out with the full force of our laws.”

House Speaker Ron Mariano pledged the previous week to bring the bill forward, linking it to the June celebration of Pride Month.

“We have couples where one parent is the birth parent, the other is no [biological] relation, and if something is to happen to the birth parent, the other parent has no status, so they would have to go through an adoption process,” he said.

“Marriage looks different today than it did 10 years ago, so we’re trying to keep pace with the changes that are occurring in society and not burden people for doing the right thing,” Mariano added.

Peake, who was one of eight reps to speak in favor of the bill before the final vote, suggested that the legislation is not aimed only at LGBTQ families.

“There are ways that people become parents today that couldn’t have been, all pun intended, conceived of when some of these statutes were written,” she said.

“We may be taking up this bill during Pride Month, but I would respectfully submit to my colleagues: this isn’t a bill that is just benefiting the LGBTQ community. This is a bill that is good for everybody in the commonwealth of Massachusetts,” Peake added.

The Christian faith-based advocacy organization Massachusetts Family Institute opposed the legislation, saying it could deprive children of the ability to know their biological mother and/or father, and reduce children to a commodity.

“These bills would prioritize the desires of adults over the needs of children in the Commonwealth. They would make it easier for people to purchase children through surrogacy arrangements and sperm or egg donorship. In doing so, they would harm both children and parents,” the organization said in an alert to its supporters.

The bill sailed through the House by a 156-0 vote after emotional speeches of support delivered by both Democrats and Republicans.

Republican Rep. Hannah Kane of Shrewsbury at one point choked up while describing the three children she has with her husband.

“Our parentage was easily established as the laws that exist made it clear and easy to do so. Our beautiful, smart, sweet, tough Endicott College graduate and national collegiate rugby champion, Caitlin, our daughter, is lesbian. If she chooses to, I want her to experience the joy of being a parent some day with the same rights to establish her parentage and the same legal protections as her dad and I did,” Kane told her colleagues. “I want our future grandchildren to have the security of legal parentage, regardless of the circumstances of our birth, and I want that for all LGBTQ+ families. For our daughter and countless others like her, legal parentage is not just a matter of paperwork or bureaucracy. It is a matter of identity, belonging and affirmation.”

The bill’s breezy passage was a sharp contrast from the tense legislative debate around same-sex marriage 20 years ago. Years after the Supreme Judicial Court’s 2003 decision in Goodridge, et al. v. Dept. Public Health declared it unconstitutional to deny same-sex couples the ability to marry, the House and Senate together derailed a proposed Constitutional amendment that would have defined marriage as between a man and a woman.

“Today, we continue on that worthy pathway, recognizing the love and commitment of parents and meeting them as they are,” Day said. “Today, we say no to those oracles of misery who would deprive a parent of the full rights and privileges of parenthood because that person is different from their image of what a parent should look like.”

https://masslawyersweekly.com/2024/06/13/house-unanimously-approves-parentage-equality-bill/


Supreme Court Rejects Challenge To Abortion Drug Mifepristone

 by Matthew Vadum via The Epoch Times,

The Supreme Court unanimously rejected a challenge Thursday morning brought by a doctors’ group against the Food and Drug Administration’s (FDA) loosening of regulations of the abortion pill mifepristone, handing a win to the agency.

The court held that those challenging the status of the pill lacked legal standing to do so.

The decision came two years after the court’s landmark 2022 ruling in Dobbs v. Jackson Women’s Health Organization, which overturned Roe v. Wade and returned the regulation of abortion to the states.

The 9–0 opinion was written by Justice Brett Kavanaugh. Justice Clarence Thomas filed a concurring opinion.

Medication abortions are reportedly lawful in 36 states and the District of Columbia.

A medication abortion generally involves the use of mifepristone, which blocks progesterone, a hormone, and misoprostol, which induces contractions. Misoprostol, which is widely available because it has many medical uses, isn’t an issue in the current litigation. Also known as mifeprex and RU-486, mifepristone is made by Danco Laboratories.

Advocates for mifepristone said the current system by which the drug is provided is safe, while opponents said it puts women at risk by ignoring safety measures that used to be in place.

The Biden administration and pro-abortion groups warned that the Supreme Court’s eventual decision in the case could affect the drug’s availability.

The case is actually two appeals that the court consolidated - Food and Drug Administration (FDA) v. Alliance for Hippocratic Medicine (AHM) and Danco Laboratories LLC v. AHM.

The Supreme Court case came after Judge Matthew Kacsmaryk of the U.S. District Court for the Northern District of Texas, an appointee of President Donald Trump, held in April 2023 that the FDA was wrong to approve mifepristone for public use in 2000. He said the FDA was under political pressure to get the pill on the market and then, after that, had deliberately dragged out judicial review of the drug for years.

Judge Kacsmaryk found the FDA had improperly lifted restrictions related to accessing the drug and issued a preliminary nationwide injunction retroactively staying the FDA’s approval.

In 2016, the FDA changed the drug’s official label, extending the cutoff for use from 49 days of gestation to 70 days. At the same time, the agency allowed the drug to be prescribed with only one in-person visit and halted the requirement that prescribers report nonfatal adverse events.

In 2021, the agency allowed patients to receive the drug by mail instead of having to pick it up in person from a specially certified health care provider.

The U.S. Court of Appeals for the 5th Circuit refused to block most of Judge Kacsmaryk’s ruling, holding that the FDA’s actions in 2016 and 2021 were probably unlawful. The Supreme Court blocked the injunction over the original approval of the drug, allowing mifepristone to remain on the market, but pointedly refused to agree to commit to examining whether the original approval of the drug in 2000 was lawful.

During oral arguments at the Supreme Court on March 26, much of the discussion focused on legal standing, that is, the connection a litigant has to a controversy before the court.

This is a developing story...

https://www.zerohedge.com/political/supreme-court-rejects-challenge-abortion-drug-mifepristone

Moderna Positive Phase 3 Efficacy Data for Next Gen COVID-19 Vaccine

 mRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and older

Higher efficacy was observed in mRNA-1283 compared to Spikevax in adults 18 years of age and older

https://www.accesswire.com/876794/moderna-announces-positive-phase-3-efficacy-data-for-mrna-1283-the-companys-next-generation-covid-19-vaccine

FAA was 'too hands off' in Boeing oversight before 737 MAX 9 incident

 The head of the Federal Aviation Administration said Thursday the agency was "too hands off" in oversight of Boeing before a Jan. 5 mid-air emergency in a new Alaska Airlines 737 MAX 9.

"The FAA should have had much better visibility into what was happening at Boeing before Jan. 5," said FAA Administrator Mike Whitaker at a Senate Commerce Committee hearing.

He said the agency had permanently boosted the use of in-person inspectors and would visit a Boeing factory in South Carolina on Friday. "The FAA's approach before then "was too hands off, too focused on paperwork audits and not focused enough on inspections," Whitaker added.

https://www.marketscreener.com/business-leaders/MIKE-WHITAKER-12737/news/FAA-was-too-hands-off-in-Boeing-oversight-before-737-MAX-9-incident-46968124/

Gov. DeSantis Declares Emergency As South Florida Swamped By Heavy Rains

 A tropical disturbance has swamped South Florida with torrential downpours, flooding city streets and highways and sparking life-threatening conditions for millions of residents. The governor has declared an emergency over flooding concerns. 

The National Hurricane Center has reported that an unorganized tropical system is sweeping across Florida from the Gulf of Mexico to the Atlantic. This storm coincided with the beginning of the 2024 Atlantic Hurricane season. 

Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3

 Sarepta stock jumped Thursday after Pfizer's (PFE) rival gene therapy for Duchenne muscular dystrophy failed in final-phase testing.

The news gives Sarepta Therapeutics (SRPT) an edge heading to June 21, when the Food and Drug Administration will decide whether to fully approve Elevidys for patients with the muscle-wasting disease. Elevidys has accelerated approval to treat children age 4 and 5 who can still walk. But Sarepta hopes the FDA will allow older and non-ambulatory children to receive the gene therapy.

For Pfizer, the results are the "final nail in the coffin for the program," Leerink Partners analyst Joseph Schwartz said in a report. Pfizer is still evaluating its next steps, but Schwartz says it's unlikely Pfizer will move forward with the gene therapy.

https://www.investors.com/news/technology/sarepta-stock-pfizer-gene-therapy-failure-duchenne-muscular-dystrophy/

AbbVie, FutureGen in License Agreement to Develop Next-Gen IBD Therapy

 AbbVie (NYSE: ABBV) and FutureGen Biopharmaceutical (Beijing) Co., Ltd. today announced a license agreement to develop FG-M701, a next generation TL1A antibody for the treatment of IBD currently in preclinical development.

FG-M701 is a fully human monoclonal antibody targeting TL1A, a clinically validated target in IBD. FG-M701 is uniquely engineered with potential best-in-class functional characteristics compared to first-generation TL1A antibodies with the goal to drive greater efficacy and less frequent dosing as a therapy for IBD.

https://www.prnewswire.com/news-releases/abbvie-and-futuregen-announce-license-agreement-to-develop-next-generation-therapy-for-inflammatory-bowel-disease-302171900.html